A Phase II Study of a Combination of MTA (LY231514) and Gemcitabine in Patients With Metastatic Breast Cancer. [clinicaltrials:NCT00034489]
A Phase II Study of a Combination of MTA (LY231514) and Gemcitabine in Patients With Metastatic Breast Cancer. [clinicaltrials:NCT00034489]
Bio2RDF identifier
NCT00034489
Bio2RDF namespace
clinicaltrials
Bio2RDF uri
http://bio2rdf.org/clinicaltrials:NCT00034489
identifiers.org URI
authority [clinicaltrials_vocabulary:authority]
brief summary [clinicaltrials_vocabulary:brief-summary]
This is a study to expl ...... ane
chemotherapy drugs.
brief title [clinicaltrials_vocabulary:brief-title]
A Phase II Study of a Combinat ...... With Metastatic Breast Cancer.
condition [clinicaltrials_vocabulary:condition]
condition browse [clinicaltrials_vocabulary:condition-browse]
condition mesh [clinicaltrials_vocabulary:condition-mesh]
country [clinicaltrials_vocabulary:country]
detailed description [clinicaltrials_vocabulary:detailed-description]
Gemcitabine is given by ...... he possibility of a rash.

download date [clinicaltrials_vocabulary:download-date]
ClinicalTrials.gov processed this data on August 10, 2015
eligibility [clinicaltrials_vocabulary:eligibility]
firstreceived date [clinicaltrials_vocabulary:firstreceived-date]
2002-04-29T00:00:00Z
intervention [clinicaltrials_vocabulary:intervention]
intervention browse [clinicaltrials_vocabulary:intervention-browse]
keyword [clinicaltrials_vocabulary:keyword]
combination therapy
metastatic breast cancer
lastchanged date [clinicaltrials_vocabulary:lastchanged-date]
2006-07-18T00:00:00Z
lead sponsor [clinicaltrials_vocabulary:lead-sponsor]
location [clinicaltrials_vocabulary:location]
nct id [clinicaltrials_vocabulary:nct-id]
NCT00034489
official title [clinicaltrials_vocabulary:official-title]
A Phase II Study of a Combinat ...... With Metastatic Breast Cancer.
org study id [clinicaltrials_vocabulary:org-study-id]
overall status [clinicaltrials_vocabulary:overall-status]
oversight [clinicaltrials_vocabulary:oversight]
phase [clinicaltrials_vocabulary:phase]
secondary id [clinicaltrials_vocabulary:secondary-id]
H3E-MC-JMCF
source [clinicaltrials_vocabulary:source]
study design [clinicaltrials_vocabulary:study-design]
study type [clinicaltrials_vocabulary:study-type]
url [clinicaltrials_vocabulary:url]
verification date [clinicaltrials_vocabulary:verification-date]
2006-07-01T00:00:00Z
identifier
clinicaltrials:NCT00034489
title
A Phase II Study of a Combinat ...... With Metastatic Breast Cancer.
@en
type
label
A Phase II Study of a Combinat ...... . [clinicaltrials:NCT00034489]
@en